Mohammed Hosny’s Post

Expert Perspective - Hear from Key Opinion Leaders in Surgical Oncology from around the world: why SCOUT® is the Global Leader in Breast Localization! In Support of Breast Conservation: Learn from Ralph Corsetti, MD of Tulane University how they currently use multiple SCOUT reflectors to support and enable oncoplastic breast conservation, and the implications of SCOUT MD™

Expert Perspective - Hear from Key Opinion Leaders in Surgical Oncology from around the world: why SCOUT® is the Global Leader in Breast Localization! In Support of Breast Conservation: Learn from Professor Michael Dixon of the University of Edinburgh how they currently use multiple SCOUT reflectors to support and enable oncoplastic breast conservation, and the implications of SCOUT MD™

Learn more about the Annals of Surgical Oncology journal in our latest SSO President Update in which Dr. DeMatteo interviews ASO Editor-in-Chief, Dr. Kelly McMasters. Watch Now: https://lnkd.in/ggYGJvCD Don't forget to subscribe to never miss an SSO President Update!

From our special issue on ocular oncology, this brief review highlights issues with the current classification systems for intraocular retinoblastoma (ICRB and IIRC) and presents a theoretical framework for merging 2 existing classifications and subdividing the expanded group E, thereby preserving the ability to reanalyze existing published data. https://lnkd.in/ezYCHwy7 #Ophthalmology #VisionScience #OcularOncology #Retinoblastoma

Are you attending the 2024 Asia Conference on Lung Cancer? Meeting Dr. Alex Adjei, a leading voice in thoracic oncology, is going to be an invaluable experience. Don't miss this opportunity to gain insights and discuss the latest advancements in the field and how to get published in JTO, the IASLC's premier journal. #ACLC24 #IASLC #JTO

Should we rethink the classification of G2 pancreatic neuroendocrine tumors? This study highlights the behavioral differences between G2a (Ki67 <10%) and G2b (10–20%) PanNETs. Tumors classified as G2b exhibit metastatic tendencies similar to G3, suggesting the need for distinct management approaches. Explore the implications for evolving protocols in Annals of Surgical Oncology: https://ow.ly/YwuC50UmAM4

New 10-year data from a randomized trial sheds light on the survival outcomes of cytoreduction and HIPEC with mitomycin C vs. oxaliplatin for appendiceal neoplasm with peritoneal dissemination. These findings provide critical insights for tailoring HIPEC treatments. Read the full study in Annals of Surgical Oncology: https://lnkd.in/gbmy4qMf #FeaturedArticle

📄 New research in Annals of Surgical Oncology addresses the important question: To revise or not revise? in patients with isolated margin positivity after resection of localized pancreatic ductal adenocarcinoma. Through a hybrid analysis, Elshami et al. assess the proportion of patients who might benefit from margin revision. Read the full study to explore their findings and the potential impact on surgical decision-making: https://ow.ly/vuSn50SZn7F #FeaturedArticle #SSO #SurgicalOncology

Read this Annals of Surgical Oncology #Featured Article that reports on an externally validated delta radiomics-based model developed to predict overall survival, disease-free survival & the likelihood of achieving an R0 resection in patients with pancreatic ductal adenocarcinoma. 📃: https://ow.ly/ePWW50R9Lb0

Catch the recorded Qualitative Research in Thoracic Oncology Webinar, now available on #IASLC's #LC360. This session delves into the role of qualitative research studies within the thoracic oncology patient population, providing a comprehensive overview of research methods, design, and the formulation of research questions. Enhance your understanding of this vital topic by watching now: https://lnkd.in/gr9Cv4k8 #LCSM